A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and vulvovaginal melanomas: A trial of the ECOG-ACRIN Cancer Research Group (E2607) Meeting Abstract
| Authors: | Kalinsky, K.; Lee, S. J.; Rubin, K. M.; Lawrence, D. P.; Iafrate, A. J.; Borger, D. R.; Margolin, K. A.; Leitao, M. M.; Koon, H. B.; Tarhini, A. A.; Pecora, A.; Cohen, G. I.; Kuzel, T.; Kirkwood, J. M. |
| Abstract Title: | A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and vulvovaginal melanomas: A trial of the ECOG-ACRIN Cancer Research Group (E2607) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 484s |
| Language: | English |
| ACCESSION: | WOS:000404711507123 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9501 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9501 -- Source: Wos |
